nhia logo

Quick Links
Search NHIA.org


Patient Safety

Counce J and Kramer N. Case management of the challenging IgG patient: Clinical considerations for the most effective and safe therapy.2009:15(4);S1-S8.

Counce J. Always on duty combining dedication and emergency preparedness to endure "super storm Sandy." 2013;19(2):20-8.

Counce J. Weaving safety into everyday practice how one provider is building a culture of safety in its practice. 2013;19(2):30-7.

Counce J and Noyes B. Medicare competitive bidding and external infusion pumps: Cutting beneath the savings into quality patient care. 2013;19(5):29-34.

Counce J and Grissinger M. Delving into the unknown unknowns: Using Failure Mode and Effects Analysis (FMEA) to root out risk in home and specialty infusion pharmacy. 2014;20(2):29-35.

Counce J. FDA Inspections—preparing and protecting your home infusion pharmacy. 2016;22(6):25-26.

Counce. Aseptic Technique—health care’s ubiquitous, but unstandardized best tool for fighting microbial contamination. 2016;22(6):37-44.

Guenter P and Hancock T. Enteral connector standards: Preparing to adopt ENFit and improve patient safety. 2014;20(4):27-32.

Heagy K and Kramer N. Crossing the Cultural Divide—Cultural Competence is Critical to Safe and Effective Health Care. 2010:16(3);32-7.

Iltz J. Thinking inside the box: Do compounded sterile preparations maintain refrigerated conditions during transit? 2013;19(2):39-44.

Kastango E. Maintaining a state of control in sterile compounding—The intersection of professional responsibility and patient safety. 2013;19(6):28-35.

Kramer N and Krutsinger K. Reducing heparin concentrations in the home care setting: A case study. 2009:15(1);21-4.

Kramer N. Preventing Central Line-Associated Bloodstream Infections in the Home-Based Patient: Crafting and industry-specific dressing change procedure. 2011; 17(2):30-6.

McGarity GJ and Ariano RE. Gentamicin: The case for litigation prophylaxis. 2014;20(2):37-44.

Ngo A, Harris J, Fancher T, and Rogers W. A case study in collaborating to safely and efficiently dispose of medical and hazardous waste in the home care setting. 2015;21(1):28-34.

Nowobilski-Vasilios A and Bing C. Beyond-use dating of compounded sterile preparations—Effectively mapping out the complexities for better decision making. 2013;19(6):37-45.

Nowobilski-Vasilios A. Our personal responsibility in an environment of change. 2014;20(6):15-17.

Parry AM and Counce J. Health literacy: An essential tool for patients and important consideration in patient and caregiver education. 2013;19(4):33-41.

Petroff B and Baczewski D. Blueprint for Patient Safety: How informed clean room design can promote sterility. INFUSION.2015;21(6):27-33.

Rahn T. Patient safety in the home care setting: Tools for recognizing concerns and taking preemptive action. 2015;21(2):27-31.

Rappa E and Ness S. Balancing medication access and risk: What the FDA's REMS programs mean for infusion pharmacy. 2011; 17(6):16-23.

Sullivan C. Sterile Compounding in the Future: How Newly Proposed USP Standards Could Affect Your Practice. INFUSION.2015;21(6):22-25.

Sullivan C. Maintaining a Controlled Environment: Cleaning and disinfecting in the clean room. INFUSION.2015;21(6):36-43.

Sullivan C and Van Pool K. Sterile Compounding Federal Regulatory Roundup. 2016;22(6):16-21.

Tharp J. Strategies for proactively managing the risk points associated with drug shortages. 2015;21(2):32-44.

Van Pool K. Parsing Oversight of Home Infusion Pharmacies Under the Drug Quality and Security Act. INFUSION.2015;21(6):13-14.